PRN: BioNeutral Announces Caliber Sales Engineering as an Authorized Dealer

PRN: BioNeutral Announces Caliber Sales Engineering as an Authorized Dealer.

Persone Vivian Alvarez
Luoghi Sweden, Germany, United Kingdom, France, United States of America, New Jersey, Newark
Organizzazioni Institute of Technology, Caliber Sales Engineering Inc., BioNeutral Group Inc., Environmental Protection Agency, Food and Drug Administration, Securities and Exchange Commission, Bloomberg L.P.
Argomenti commerce, economics

16/giu/2011 15.03.35 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

BioNeutral Announces Caliber Sales Engineering as an Authorized Dealer

 
[16-June-2011]
 

NEWARK, New Jersey, June 16, 2011 /PRNewswire/ --


BioNeutral Group Inc., (OTCBB: BONU) today announced the appointment of Caliber Sales Engineering Inc. as an authorized dealer of its EPA approved Ygiene Hospital and Military Grade sterilant.  BioNeutral Ygiene product is used to sterilize any hard surface in only 20 minutes.  The product has demonstrated utility and effectiveness in industrial, health care and military settings,  at the onset, the distribution agreement will be limited to sales opportunities within the United States.

Caliber Sales Engineering Inc. is celebrating its 25th Anniversary representing many premier defense equipment manufacturers in the military aviation, marine, and tactical markets.  Caliber  has a proven track record  in providing support for legacy systems from high profile companies such as Northrop Grumman, Lockheed Martin, Raytheon, and other major U.S. manufacturers.

For more information on Caliber go to: http://www.calibersales.com/caliber/

Ygiene formulations are non corrosive and can be used in close proximity to electronics and high grade stainless steel components.  

"We at Caliber are excited about this opportunity and look forward to working with BioNeutral and in leveraging our distribution platform to market the all new and very unique Ygiene product platform," stated Vivian Alvarez, Director of Operations at Caliber Sales Engineering.

About BioNeutral Group, Inc.

Headquartered at the New Jersey Institute of Technology/EDC in Newark, NJ, BioNeutral Group, Inc., is a specialty technology-based life science company which has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, Ygiene® and Ogiene®, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. Its antimicrobial line of products under the Ygiene® brand have been approved by the EPA for sale in the United States, has previously been approved for sale in Germany and is also permitted for sale in the UK, France and Sweden. AutoNeutral is a registered trademark of BioNeutral Group, Inc. For more information on BioNeutral, including a listing of the Company's products, leadership and background, please visit http://www.bioneutralgroup.com.

Find us on Facebook: http://www.facebook.com/pages/BioNeutral-Group/149109938452393

Follow us on Twitter: http://twitter.com/bioneutralgroup

Forward-Looking Statements

This release contains certain "forward-looking statements" relating to the business of the Company and its subsidiary companies. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. Such forward looking statements involve known and unknown risks and uncertainties that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those described in the Company's filings with the Securities and Exchange Commission. BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA has approved and registered the Company's data and findings specific to Ygiene®-206. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene® and will soon be available for sale in the United States.



Company Codes: NASDAQ-OTCBB:BONU, Bloomberg:BONU@US
blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl